Top

Published in:

01-01-2018 | Neurology and Preclinical Neurological Studies - Original Article

Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort

Authors: Claus-Jürgen Scholz, Heike Weber, Susanne Jungwirth, Walter Danielczyk, Andreas Reif, Karl-Heinz Tragl, Peter Fischer, Peter Riederer, Jürgen Deckert, Edna Grünblatt

Published in: Journal of Neural Transmission | Issue 1/2018

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder that preferentially affects individuals of advanced age. Heritability estimates for AD range between 60 and 80%, but only few genetic risk factors have been identified so far. In the present explorative study, we aimed at characterizing the genetic contribution to late-onset AD in participants of the Vienna Transdanube Aging (VITA) longitudinal birth cohort study in a two-step approach. First, we performed a genome-wide screen of pooled DNA samples (n = 588) to identify allele frequency differences between AD patients and non-AD individuals using life-time diagnoses made at the age of 80 (t = 60 months). This analysis suggested a high proportion of brain-expressed genes required for cell adhesion, cell signaling and cell morphogenesis, and also scored in known AD risk genes. In a second step, we confirmed associations using individual genotypes of top-ranked markers examining AD diagnoses as well as the dimensional scores: FULD and MMSE determined up to the age of 82.5 (t = 90 months). Taken together, our study proposes genes ANKS1B, ENST00000414107, LOC100505811, SLC22A14, QRFPR, ZDHHC8P1, ADAMTS3 and PPFIA1 as possible new candidates involved in the etiology of late-onset AD, with further research being needed to clarify their exact roles.

Available only for authorised users

Abraham R, Moskvina V, Sims R, Hollingworth P, Morgan A, Georgieva L, Dowzell K, Cichon S, Hillmer AM, O’Donovan MC et al (2008) A genome-wide association study for late-onset Alzheimer’s disease using DNA pooling. BMC Med Genomics 1:44CrossRefPubMedPubMedCentral

Allen Institute for Brain Science (2016) Allen Brain Atlas. http://www.brain-map.org/. Accessed 13 Feb 2016

Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An english translation of Alzheimer’s 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”. Clin Anat 8(6):429–431CrossRefPubMed

Ashford JW, Mortimer JA (2002) Non-familial Alzheimer’s disease is mainly due to genetic factors. J Alzheimers Dis 4(3):169–177CrossRefPubMed

Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, Fraser G, Kesler S, Levin SM, Lucey B et al (2014) Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease. Neurobiol Aging 35(Suppl 2):S74–S78CrossRefPubMed

Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA (2012) Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69(5):493–498CrossRefPubMedPubMedCentral

Bartl J, Scholz CJ, Hinterberger M, Jungwirth S, Wichart I, Rainer MK, Kneitz S, Danielczyk W, Tragl KH, Fischer P et al (2011) Disorder-specific effects of polymorphisms at opposing ends of the insulin degrading enzyme gene. BMC Med Genet 12:151CrossRefPubMedPubMedCentral

Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG et al (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer’s disease and related dementias. PLoS Genet 10(9):e1004606CrossRefPubMedPubMedCentral

Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39(1):17–23CrossRefPubMed

Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: back to the future. Neuron 68(2):270–281CrossRefPubMed

Butterfield DA, Di Domenico F, Barone E (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta 1842(9):1693–1706CrossRefPubMedPubMedCentral

Cooper JK (2014) Nutrition and the brain: what advice should we give? Neurobiol Aging 35(Suppl 2):S79–S83CrossRefPubMed

Davis OS, Plomin R, Schalkwyk LC (2009) The SNPMaP package for R: a framework for genome-wide association using DNA pooling on microarrays. Bioinformatics 25(2):281–283CrossRefPubMed

Fischer P, Jungwirth S, Krampla W, Weissgram S, Kirchmeyr W, Schreiber W, Huber K, Rainer M, Bauer P, Tragl KH (2002) Vienna Transdanube Aging “VITA”: study design, recruitment strategies and level of participation. J Neural Transm Suppl 62:105–116CrossRef

Fischer P, Zehetmayer S, Jungwirth S, Weissgram S, Krampla W, Hinterberger M, Torma S, Rainer M, Huber K, Hoenigschnabl S et al (2008) Risk factors for Alzheimer dementia in a community-based birth cohort at the age of 75 years. Dement Geriatr Cogn Disord 25(6):501–507CrossRefPubMed

Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40(7):812CrossRefPubMed

Fuld PA (1980) Guaranteed stimulus-processing in the evaluation of memory and learning. Cortex 16(2):255–271CrossRefPubMed

Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63(2):168–174CrossRefPubMed

Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5(10):R80CrossRefPubMedPubMedCentral

Ghersi E, Vito P, Lopez P, Abdallah M, D’Adamio L (2004) The intracellular localization of amyloid beta protein precursor (AbetaPP) intracellular domain associated protein-1 (AIDA-1) is regulated by AbetaPP and alternative splicing. J Alzheimers Dis 6(1):67–78CrossRefPubMed

Grünblatt E, Schlosser R, Fischer P, Fischer MO, Li J, Koutsilieri E, Wichart I, Sterba N, Rujescu D, Moller HJ et al (2005) Oxidative stress related markers in the “VITA” and the centenarian projects. Neurobiol Aging 26(4):429–438CrossRefPubMed

Grünblatt E, Hupp E, Bambula M, Zehetmayer S, Jungwirth S, Tragl KH, Fischer P, Riederer P (2006a) Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the “VITA” study. J Affect Disord 96(1–2):111–116CrossRefPubMed

Grünblatt E, Loffler C, Zehetmayer S, Jungwirth S, Tragl KH, Riederer P, Fischer P (2006b) Association study of the 5-HTTLPR polymorphism and depression in 75-Year-Old nondemented subjects from the Vienna Transdanube Aging (VITA) study. J Clin Psychiatry 67(9):1373–1378CrossRefPubMed

Grünblatt E, Reif A, Jungwirth S, Galimberti D, Weber H, Scarpini E, Sauer C, Wichart I, Rainer MK, Huber K et al (2011) Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer’s disease: the VITA and Milano studies. J Psychiatr Res 45(9):1250–1256CrossRefPubMed

Guerreiro R, Bras J, Hardy J (2013) SnapShot: genetics of Alzheimer’s disease. Cell 155(4):968–968, e961

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41(10):1088–1093CrossRefPubMedPubMedCentral

Hohman TJ, Bell SP, Jefferson AL (2015) Alzheimer’s disease neuroimaging I: the role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease. JAMA Neurol 72(5):520–529CrossRefPubMedPubMedCentral

Hollingworth P, Harold D, Jones L, Owen MJ, Williams J (2011a) Alzheimer’s disease genetics: current knowledge and future challenges. Int J Geriatr Psychiatry 26(8):793–802CrossRefPubMed

Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V et al (2011b) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet 43(5):429–435CrossRefPubMedPubMedCentral

Homer N, Tembe WD, Szelinger S, Redman M, Stephan DA, Pearson JV, Nelson SF, Craig D (2008) Multimarker analysis and imputation of multiple platform pooling-based genome-wide association studies. Bioinformatics 24(17):1896–1902CrossRefPubMedPubMedCentral

International HapMap C, Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P et al (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449(7164):851–861CrossRef

Jacob AL, Jordan BA, Weinberg RJ (2010) Organization of amyloid-beta protein precursor intracellular domain-associated protein-1 in the rat brain. J Comp Neurol 518(16):3221–3236CrossRefPubMedPubMedCentral

Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Leppanen VM, Holopainen T, Kivela R, Ortega S, Karpanen T, Alitalo K (2014) CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation. Circulation 129(19):1962–1971CrossRefPubMed

Jiao B, Liu X, Zhou L, Wang MH, Zhou Y, Xiao T, Zhang W, Sun R, Waye MM, Tang B et al (2015) Polygenic analysis of late-onset Alzheimer’s disease from Mainland China. PLoS One 10(12):e0144898CrossRefPubMedPubMedCentral

Jordan BA, Fernholz BD, Khatri L, Ziff EB (2007) Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons. Nat Neurosci 10(4):427–435CrossRefPubMed

Jordan KW, Craver KL, Magwire MM, Cubilla CE, Mackay TF, Anholt RR (2012) Genome-wide association for sensitivity to chronic oxidative stress in Drosophila melanogaster. PLoS One 7(6):e38722CrossRefPubMedPubMedCentral

Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, Chang KA, Yu E, Jeong SJ, Chong YH et al (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J 17(13):1951–1953PubMed

Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63(3):287–303CrossRefPubMedPubMedCentral

Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41(10):1094–1099CrossRefPubMed

Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458CrossRefPubMedPubMedCentral

Le Goff C, Somerville RP, Kesteloot F, Powell K, Birk DE, Colige AC, Apte SS (2006) Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis. Development 133(8):1587–1596CrossRefPubMed

Lee DK, Nguyen T, Lynch KR, Cheng R, Vanti WB, Arkhitko O, Lewis T, Evans JF, George SR, O’Dowd BF (2001) Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 275(1):83–91CrossRefPubMed

Macgregor S, Visscher PM, Montgomery G (2006) Analysis of pooled DNA samples on high density arrays without prior knowledge of differential hybridization rates. Nucleic Acids Res 34(7):e55CrossRefPubMedPubMedCentral

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34(7):939–944CrossRefPubMed

Musicco M (2009) Gender differences in the occurrence of Alzheimer’s disease. Funct Neurol 24(2):89–92PubMed

Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet 43(5):436–441CrossRefPubMedPubMedCentral

Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS et al (2014) Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol 71(11):1394–1404CrossRefPubMedPubMedCentral

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575CrossRefPubMedPubMedCentral

Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11(2):111–128PubMedPubMedCentral

R Core Team (2015) R: a language and environment for statistical computing. 3.2.0 edn. R Foundation for Statistical Computing

Reif A, Grünblatt E, Herterich S, Wichart I, Rainer MK, Jungwirth S, Danielczyk W, Deckert J, Tragl KH, Riederer P et al (2011) Association of a functional NOS1 promoter repeat with Alzheimer’s disease in the VITA cohort. J Alzheimers Dis 23(2):327–333PubMed

Scholz CJ, Jungwirth S, Danielczyk W, Weber H, Wichart I, Tragl KH, Fischer P, Riederer P, Deckert J, Grünblatt E (2014) Investigation of association of serotonin transporter and monoamine oxidase-A genes with Alzheimer’s disease and depression in the VITA study cohort: a 90-month longitudinal study. Am J Med Genet B Neuropsychiatr Genet 165B(2):184–191CrossRefPubMed

Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, Smith AV, Carassquillo MM, Lambert JC et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832–1840CrossRefPubMedPubMedCentral

Slomnicki LP, Lesniak W (2008) A putative role of the amyloid precursor protein intracellular domain (AICD) in transcription. Acta Neurobiol Exp (Wars) 68(2):219–228

Spangler SA, Hoogenraad CC (2007) Liprin-alpha proteins: scaffold molecules for synapse maturation. Biochem Soc Trans 35(Pt 5):1278–1282CrossRefPubMed

Stern Y (2012) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 11(11):1006–1012CrossRefPubMedPubMedCentral

Takayasu S, Sakurai T, Iwasaki S, Teranishi H, Yamanaka A, Williams SC, Iguchi H, Kawasawa YI, Ikeda Y, Sakakibara I et al (2006) A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice. Proc Natl Acad Sci USA 103(19):7438–7443CrossRefPubMedPubMedCentral

Tosto G, Reitz C (2013) Genome-wide association studies in Alzheimer’s disease: a review. Curr Neurol Neurosci Rep 13(10):381CrossRefPubMedPubMedCentral

Vucicevic D, Schrewe H, Orom UA (2014) Molecular mechanisms of long ncRNAs in neurological disorders. Front Genet 5:48PubMedPubMedCentral

Weissflog L, Scholz CJ, Jacob CP, Nguyen TT, Zamzow K, Gross-Lesch S, Renner TJ, Romanos M, Rujescu D, Walitza S et al (2013) KCNIP4 as a candidate gene for personality disorders and adult ADHD. Eur Neuropsychopharmacol 23(6):436–447CrossRefPubMed

Title: Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort
Authors: Claus-Jürgen Scholz
Heike Weber
Susanne Jungwirth
Walter Danielczyk
Andreas Reif
Karl-Heinz Tragl
Peter Fischer
Peter Riederer
Jürgen Deckert
Edna Grünblatt
Publication date: 01-01-2018
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 1/2018
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-017-1796-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Proteasome-mediated degradation of tyrosine hydroxylase triggered by its phosphorylation: a new question as to the intracellular location at which the degradation occurs

Japanese medicine and Berlin: a very special and successful relationship

Genetic manipulation of specific neural circuits by use of a viral vector system

Parkinson’s disease pathogenesis from the viewpoint of small fish models

A systematic meta-analysis of the association of Neuregulin 1 (NRG1), d-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia

Cyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum